Two more cases of H7N9 bird flu virus have been detected in Zhejiang province, including a man who died last week, authorities said on Wednesday.
浙江省卫生厅周三发布通报,该省确诊2例人感染H7N9禽流感病例,其中1名患者已于上周死亡。

The Chinese Center for Disease Control and Prevention confirmed that a 38-year-old patient surnamed Hong from Hangzhou, the provincial capital, who died in hospital on March 27, had the virus.
中国疾病预防控制中心证实,浙江省省会杭州市1名38岁姓洪的病人于3月27日病故,据检测他有感染H7N9禽流感病毒。

Hong was infected on March 7 while working in neighboring Jiangsu province. He returned home on March 18, according to the Zhejiang health department.
据浙江省卫生厅消息,洪某是3月7日在邻省江苏省工作时感染上病毒的,随后于3月18日返回了浙江省的家中。

The other patient, surnamed Yang, is a 67-year-old man. He developed a cough and fever on March 25 and was admitted to hospital on Tuesday.
另一名患者杨某现年67岁,3月25日开始出现咳嗽发烧的症状,周二入院治疗。

None of the people who came into close contact with the patients have developed symptoms of the flu, the health department said.
卫生厅表示,同患者有过亲密接触的其他人员目前均未出现禽流感症状。

On Sunday, two men in Shanghai died from H7N9. A woman in Anhui province and four men in Jiangsu province remain in critical condition.
上周日,上海2名H7N9禽流感患者抢救无效死亡;1名安徽女患者和4名江苏患者目前仍处于病危状态。

All patients had fevers and coughs in the early stages before developing pneumonia and breathing difficulties, China's health authorities said.
中国卫生部门表示,所有患者在早期都表现为发烧咳嗽,随后发展为肺炎、呼吸困难等症状。

Experts say genetic analysis shows the H7N9 virus can be treated with Tamiflu, an antiviral drug that may slow the spread of influenza in the body.
专家称,根据基因序列分析显示,抗流感病毒药物达菲可以减缓流感病毒在体内的传播,可用于H7N9禽流感的早期治疗。

Wang Xianjun, head of the Shandong provincial center of disease control, said H7N9 is sensitive to neuraminidase-inhibiting medicine such as Tamiflu, Qilu Evening News reported on Wednesday.
齐鲁晚报周三报道,山东省疾控中心主任医师王显军表示,H7N9病毒对达菲等神经氨酸酶抑制剂类药物敏感。

There are no effective vaccines for H7N9 as yet, Wang said, but using Tamiflu may be effective in the early stages.
王显军说,目前尚无针对H7N9禽流感病毒的有效疫苗,但是达菲或许可用于该病毒的早期治疗。